Humachag, Larabel .
HRN: 17-60-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/27/2026
IV
2g
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/29/2026
IV
2gms
Q8hrs X 5 Doses
S/P Primary LTCS With Intracesarean IUD
Checking Initial Appropriateness
05/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2026
05/29/2026
IV
500mg
Q8hrs X 6 Doses
S/P Primary LTCS With Intracesarean IUD
Checking Initial Appropriateness
05/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/28/2026
05/28/2026
IV
900mg
Q8hr X 3 Doses
Sp PLTCS
Checking Initial Appropriateness